Laboratorio y líquido sinovial en la artritis reumatoide

Revista Clinica Espanola

Volumn 200, Issue SUPPL. 1, 2000, Pages 69-75

  Longo, F J López ^a   Gonzalez Fernandez C M ^a   Monteagudo Saez I ^a   Carreno Perez L ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BIOLOGICAL MARKER; RHEUMATOID FACTOR;

BLOOD; BLOOD CLOTTING; BONE REMODELING; CHEMISTRY; CYTOPLASM; FEMALE; HUMAN; IMMUNOLOGY; MALE; REVIEW; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; URINE;

ACUTE-PHASE PROTEINS; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; BLOOD COAGULATION; BONE REMODELING; CYTOPLASM; FEMALE; HUMANS; MALE; RHEUMATOID FACTOR; SYNOVIAL FLUID;

EID: 24644440164     PISSN: 00142565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Simon CH, Dijkmans BA, Breedveld FC. Variations in the monitoring and management of the side effects of antirheumatic drugs by means of laboratory tests. Clin Exp Rheumatol 1997; 15:633-639.
2. Van Leeuwen MA, Van Rijswijk MH, Van der Heijde DMFM, et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993; 32 (suppl 3):9-13.
3. Kremer JM, Furst DE, Weinblatt ME, Blotner SD. Significant changes in serum AST across hepatic histological biopsy grades: prospective analysis of 3 cohorts receiving methotrexate therapy for rheumatoid arthritis. J Rheumatol 1996; 23:459-461.
4. Hein G, Franke S, Muller A, Brauning E, Eidner T, Stein G. The determination of pyridinium crosslinks in urine and serum as a possible marker of cartilage degradation in rheumatoid arthritis. Clin Rheumatol 1997; 16:167-172.